Diabetes

Thrombus Perviousness Is Associated With Differential Treatment Outcomes Following IVT and EVT in MeVO Stroke Food Is Medicine Approach Improved Blood Sugar, Reduced Food Insecurity Demystifying GLP-1s Cardiovascular Benefits of GLP-1 RAs Methodologic Standards for Follow-Up Extension in Cardiovascular Trials Global Trends in the Burden of Ischemic Stroke Attributable to Diabetes Versus Atrial Fibrillation Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy Cardiovascular Risk Reduction With GLP-1 RA Drugs Researchers at Heart Optimizing Care in Cardiovascular-Kidney-Metabolic Syndrome: Registry Data From the Cardiometabolic Center Alliance